Publications
Research at the Leibniz Institute for Immunology focuses on the development of pioneering immune-cell therapies targeting cancer, autoimmune diseases, and chronic inflammation. While developments in this field are highly relevant within the medical community, they are also of great interest to the wider general public. The LIT has a comprehensive archive of international articles, publications, lectures, and online resources aimed at a variety of audiences. So, whoever you are, if you do not find what you are looking for, please do not hesitate to contact us.
Soares MVD, Gomez VE, Azevedo RI, Pereira PNG, Velazquez TC, Mendes L, Alho AC, Garcia-Guerrero E, Garcia-Calderon CB, Tharmaratnam K, Cabral IA, Ribeiro AC, Juncal C, Roncon S, Pais AT, Gil AR, Espada E, Rodrigues A, Garcao A, Yaspo ML, Warnatz HJ, Lehrach H, Ward L, Barbosa-Morais NL, Quintas AM et al. Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease. Blood Adv. 2026 May 12. 10:2904–2915. doi:10.1182/bloodadvances.2025017996. PMID: 41637631
Mast AS, Lang P, Schlegel P, Calkoen FG, Atar D, Scheuermann S, Klein S, Braun C, Schinle F, Schmidt M, Hensen L, Ebinger M, Doring M, Schafer JF, Schulte J, Bethge WA, Lengerke C, Alahmari B, Hu P, Schneider D, Orentas RJ, Handgretinger R, Seitz CM. Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort. J Immunother Cancer. 2026 May 21. 14doi:10.1136/jitc-2025-013901. PMID: 42167809
Huerta Arana M, Klapproth H, Stanczak MA, Bopp L, Witschurke K, Seitz R, Lopez Martinez M, Zamek J, Henschke S, Rana N, O’Sullivan D, Steinkamp J, Lackmann JW, Damsky W, von Stebut E, Sanin DE, Zigrino P, Klein Geltink RI, Pearce EJ, Pearce EL, Fabri M. A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin disease. Sci Adv. 2026 May 29. 12:eaea0773. doi:10.1126/sciadv.aea0773. PMID: 42213834
Gryksa K, Sibilia M, Rothhammer V, Liston A, Zaiss DM. The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. J Neuroinflammation. 2026 May 21. 23doi:10.1186/s12974-026-03873-5. PMID: 42169107
Weber D, Tariq M, Hazenberg M, Poeck H, Malard F. Microbiome, GvHD, and immune reconstitution in allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2026 Apr. 61:385–394. doi:10.1038/s41409-026-02798-0. PMID: 41639396
McDonald-Hyman C, Baskar PSM, Peng Y, Williams V, Brandl T, Edinger M, Hoffmann P, Blazar BR. A novel method for efficient murine regulatory T-cell expansion and retroviral transduction. Cytotherapy. 2026 Apr 8. 28:102879. doi:10.1016/j.jcyt.2026.102879. PMID: 42241898
Masopust D, Awasthi A, Bosselut R, Brooks DG, Buggert M, Chamoto K, Cui W, Dong C, Farber DL, Gebhardt T, Gerlach C, Goldrath A, Greenberg PD, Hale JS, Hayday A, Homann D, Iannacone M, Jameson SC, Jenkins MK, Joshi NS, Kaech SM, Kallies A, Kamphorst AO, Kaplan MH, Klenerman P et al. Guidelines for T cell nomenclature. Nat Rev Immunol. 2026 Apr. 26:298–313. doi:10.1038/s41577-025-01238-2. PMID: 41254224
Gattinoni L, Inchingolo G, Harrer DC, Susana A, Puccio S, Slavkovic-Lukic D, Natrakul DA, Strieder N, Heuser-Loy C, Baldwin JG, Fioravanti J, Ji Y, Gautam S, Suriano C, Martín-Santos A, Schelker RC, Patel N, Mann J, Goff S, Mikkilineni L, Yang JC, Kwong MLM, Patel R, Rehli M, Highfill SL, Stroncek DF, Rosenberg SA, Biasco L, Lugli E, Brudno JN, Kochenderfer JN. Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse. Cell. 2026 Apr 30:S0092-8674(26)00383-1. doi: 10.1016/j.cell.2026.03.047. Epub ahead of print. PMID: 42066750
Guleed S, Nguyen N, Subratheepam S, Melchiors KM, Olsen AW, Ciancaglini M, Kastner AL, Nolfi E, Pinschewer D, Follmann F, Christensen JP, Sijts A, Dietrich J. CD8(+) T cell responses recognizing immunodominant Chlamydia antigens fail to protect against infection. iScience. 2026 Apr 17. 29:115242. doi:10.1016/j.isci.2026.115242. PMID: 41952975
Harrer DC, Haferkamp S, Herr W, Mycielska M, Dorrie J, Schaft N, Abken H, Drexler K. Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of Gluconate. Pharmaceutics. 2026 Apr 30. 18doi:10.3390/pharmaceutics18050551. PMID: 42198246